RAMM Pharma Corp Analysis
RAMM Pharma's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. RAMM Pharma's financial risk is the risk to RAMM Pharma stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that RAMM Pharma's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which RAMM Pharma is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of RAMM Pharma to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, RAMM Pharma is said to be less leveraged. If creditors hold a majority of RAMM Pharma's assets, the Company is said to be highly leveraged.
RAMM Pharma Corp is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of RAMM Pharma pink sheet analysis is to determine its intrinsic value, which is an estimate of what RAMM Pharma Corp is worth, separate from its market price. There are two main types of RAMM Pharma's stock analysis: fundamental analysis and technical analysis.
The RAMM Pharma pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and RAMM Pharma's ongoing operational relationships across important fundamental and technical indicators.
RAMM |
RAMM Pink Sheet Analysis Notes
About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RAMM Pharma Corp recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmaceutical formulations, pharmaceuticals, cosmetics, nutraceutical products, and resale of medical supplies products in Canada and internationally. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Ramm Pharma is traded on OTC Exchange in the United States.The quote for RAMM Pharma Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about RAMM Pharma Corp contact Jackie Burnett at 416 848 7744 or learn more at https://www.rammpharma.com.RAMM Pharma Corp Investment Alerts
| RAMM Pharma Corp is not yet fully synchronised with the market data | |
| RAMM Pharma Corp has some characteristics of a very speculative penny stock | |
| RAMM Pharma Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 4.12 M. Net Loss for the year was (7.11 M) with loss before overhead, payroll, taxes, and interest of (37.32 K). | |
| RAMM Pharma Corp has accumulated about 12.79 M in cash with (3.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1. | |
| Roughly 35.0% of the company outstanding shares are owned by corporate insiders |
RAMM Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RAMM Pharma's market, we take the total number of its shares issued and multiply it by RAMM Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.RAMM Profitablity
The company has Profit Margin (PM) of (1.76) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.89.RAMM Pharma Corp Debt to Cash Allocation
Many companies such as RAMM Pharma, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
RAMM Pharma Corp has accumulated 8.69 K in total debt. RAMM Pharma Corp has a current ratio of 9.0, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist RAMM Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, RAMM Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RAMM Pharma Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RAMM to invest in growth at high rates of return. When we think about RAMM Pharma's use of debt, we should always consider it together with cash and equity.RAMM Pharma Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the RAMM Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of RAMM Pharma, which in turn will lower the firm's financial flexibility.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding RAMM Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |